Primary and Secondary Ventral Hernia Repair Using Long-term Resorbable Versus Non-resorbable Large Pore Synthetic Mesh. (TIGR)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Since abdominal wall hernia repair is currently performed with the use of a mesh, side effects associated with the mesh are frequently reported during long term follow-up. These side effects are related to shrinkage of the mesh, adhesions to the bowl, pain, and inflammation of the skin and bowl. To reduce or prevent these effects, a fully resorbing mesh has been developed, which provides sufficient support and strength to allow efficient recovery of the abdominal wall, but also disappear from your body in three years time, so that you no longer have any synthetic material in your body. Previous resorbing meshes also disappeared but over a much shorter period of time, so that the hernia was insufficiently healed, with recurrence as a result.
The TIGR™ mesh (the resorbable mesh used in the study) is in principle a synthetic mesh, made of two commonly used polymers, however it will retain 50% of its initial strength after six months. This in theory is enough to provide support of the collagen healing process during the initial wound-healing phase, but also to support the transition of initial collagen to functional collagen.
The aim of this study is to compare TIGR™ with large pore mesh used in the repair of the anterior abdominal wall repair (incisional hernia, umbilical hernia, etc..Inguinal hernias are not part of the study).
Therefore the patients will be divided into two groups, one group will be treated with a resorbing mesh, the other group will be treated with a permanent mesh. Otherwise there will be no difference in the medication or the surgical techniques used.
| Condition | Intervention |
|---|---|
|
Primary and Secondary Ventral Hernia |
Procedure: Placing the resorbable mesh Procedure: Non-resorbable synthetic mesh. |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Outcomes Assessor) Primary Purpose: Treatment |
| Official Title: | Recurrence Rate After Primary and Secondary Ventral Hernia Repair Using Long-term Resorbable Versus Non-resorbable Large Pore Synthetic Mesh. |
- Recurrence rate at 3 years post-surgery. [ Time Frame: 3 years post-surgery ] [ Designated as safety issue: No ]Clinical evaluation and ultrasound evaluation after 3 years post-surgery.
- Wound Morbidity 4 weeks post-surgery. [ Time Frame: 4 weeks post-surgery ] [ Designated as safety issue: No ]
- Pain and discomfort after 1 year post-surgery. [ Time Frame: After 1 year post-surgery ] [ Designated as safety issue: No ]
- Pain and discomfort after 3 years post-surgery. [ Time Frame: After 3 years post-surgery ] [ Designated as safety issue: No ]
- Recurrence rate by clinical examination 1 year post-surgery. [ Time Frame: After 1 year post-surgery. ] [ Designated as safety issue: No ]Clinical Examination to determine the recurrence rate.
| Estimated Enrollment: | 268 |
| Study Start Date: | February 2013 |
| Estimated Study Completion Date: | June 2017 |
| Estimated Primary Completion Date: | December 2016 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Resorbable mesh
Long-term resorbable mesh implanted to treat primary and secondary ventral hernia.
|
Procedure: Placing the resorbable mesh
Surgery for primary and secondary ventral hernia repair with placing of resorbable mesh.
|
|
Active Comparator: Non-resorbable mesh
Non-resorbable synthetic mesh implanted to treat primary and secondary ventral hernia.
|
Procedure: Non-resorbable synthetic mesh.
Surgery for primary and secondary ventral hernia repair with placing of non-resorbable synthetic mesh.
|
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Primary and secondary ventral hernia
- less than 20 cm in length
- less than 6 cm in width
Exclusion Criteria:
Contacts and Locations| Contact: Frederik Berrevoet, MD, PhD | Frederik.Berrevoet@ugent.be |
| Belgium | |
| Ghent University Hospital | Not yet recruiting |
| Ghent, Belgium, 9000 | |
| Contact: Frederik Berrevoet, MD, PhD +32(0)93324892 Frederik.Berrevoet@ugent.be | |
| Principal Investigator: Frederik Berrevoet, MD, PhD | |
| University Hospital Leuven | Not yet recruiting |
| Leuven, Belgium, 3000 | |
| Contact: Marc Miserez, MD, PhD Marc.miserez@uzleuven.be | |
| Principal Investigator: Marc Miserez, MD, PhD | |
| Denmark | |
| University of Copenhagen | Not yet recruiting |
| Copenhagen, Denmark, DK-2400 | |
| Contact: Lars Nannestad Jorgensen, MD, DrMSc Larsnjorgensen@hotmail.com | |
| Principal Investigator: Lars Nannestad Jorgensen, MD, DrMSc | |
| Poland | |
| ul Jagalskiego | Not yet recruiting |
| Wejherowo, Poland, 84-200 | |
| Contact: Maciej Smietanski, MD, PhD smietanski@herniaweb.org | |
| Principal Investigator: Maciej Smietanski, MD, PhD | |
| Spain | |
| Hospital de 12 Octobre | Not yet recruiting |
| Madrid, Spain | |
| Contact: Maria Teresa Butron Vila, MD | |
| Principal Investigator: Maria Teresa Butron Vila, MD | |
| United Kingdom | |
| Royal Infirmary of Edinburgh | Not yet recruiting |
| Edinburgh, United Kingdom, EH16 4SA | |
| Contact: Andrew de Beaux, MD FRCS MBcChB Andrew.Debeaux@luht.scot.nhs.uk | |
| Principal Investigator: Andrew de Beaux, MD FRCS MBChB | |
| Principal Investigator: | Frederik Berrevoet, MD, PhD | Ghent University Hospital |
More Information
Additional Information:
No publications provided
| Responsible Party: | University Hospital, Ghent |
| ClinicalTrials.gov Identifier: | NCT01622725 History of Changes |
| Other Study ID Numbers: | 2012/223 |
| Study First Received: | June 15, 2012 |
| Last Updated: | February 1, 2013 |
| Health Authority: | Belgium: Ethics Committee |
Keywords provided by University Hospital, Ghent:
|
ventral hernia |
Additional relevant MeSH terms:
|
Hernia Hernia, Ventral Pathological Conditions, Anatomical Hernia, Abdominal |
ClinicalTrials.gov processed this record on May 21, 2013